Biology of cancer and aging: A complex association with cellular senescence, J. Clin. Oncol, vol.32, pp.2604-2610, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01859025
Linking aging to chronic disease, Cell, vol.159, pp.709-713, 2014. ,
Significance of cellular senescence in aging and cancer, Cancer Res. Treat, vol.41, pp.187-195, 2009. ,
The hallmarks of aging, vol.153, pp.1194-1217, 2013. ,
The Biology of Aging and Cancer: A Brief Overview of Shared and Divergent Molecular Hallmarks. Aging Dis, vol.8, pp.628-642, 2017. ,
The evolution of lifespan and age-dependent cancer risk, Trends Cancer, vol.2, pp.552-560, 2016. ,
Role of Telomeres and Telomerase in Aging and Cancer, Cancer Discov, vol.6, pp.584-593, 2016. ,
Immunosenescence and cancer, Biogerontology, vol.18, pp.717-721, 2017. ,
Relationships between chronic obstructive pulmonary disease and lung cancer: Biological insights, J. Thorac. Dis, vol.8, pp.1122-1135, 2016. ,
Chronic obstructive pulmonary disease and lung cancer: Inter-relationships, Curr. Opin. Pulm. Med, vol.24, pp.152-160, 2018. ,
Inflammation and cancer, Environ. Health Prev. Med, vol.23, 2018. ,
Unraveling the links between cancer and aging, Carcinogenesis, vol.37, 2016. ,
Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study, JAMA Oncol, vol.4, pp.1553-1568, 2018. ,
Cancer prevalence in European registry areas, Ann. Oncol, vol.13, pp.840-865, 2002. ,
Population aging and cancer: A cross-national concern, Cancer J, vol.11, pp.437-441, 2005. ,
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study, Lancet, vol.380, pp.2095-2128, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00827612
The unmet global burden of COPD, Glob. Health Epidemiol. Genom, vol.3, 2018. ,
Facing up to the global challenges of ageing, Nature, vol.561, pp.45-56, 2018. ,
Ageing, oxidative stress and cancer: Paradigms in parallax, Nat. Rev. Cancer, vol.8, pp.875-879, 2008. ,
Telomerase at the intersection of cancer and aging, Trends Genet, vol.29, pp.513-520, 2013. ,
DNA damage response at telomeres contributes to lung aging and chronic obstructive pulmonary disease, Am. J. Physiol. Lung Cell Mol. Physiol, vol.309, pp.1124-1137, 2015. ,
Aging, inflammation and cancer, Semin. Immunol, vol.40, pp.74-82, 2018. ,
DEPTOR at the Nexus of Cancer, Metabolism, and Immunity, Physiol. Rev, vol.98, pp.1765-1803, 2018. ,
, Cancers, vol.11, p.11, 2019.
The lysosome as a cellular centre for signalling, metabolism and quality control, Nat. Cell Biol, 2019. ,
Impaired immune surveillance accelerates accumulation of senescent cells and aging, Nat. Commun, vol.9, 2018. ,
Metabolic Alterations at the Crossroad of Aging and Oncogenesis, Int. Rev. Cell Mol. Biol, vol.332, pp.1-42, 2017. ,
Artificial intelligence for aging and longevity research: Recent advances and perspectives, Ageing Res. Rev, vol.49, pp.49-66, 2019. ,
Screening older cancer patients: First evaluation of the G-8 geriatric screening tool, Ann. Oncol, vol.23, pp.2166-2172, 2012. ,
Modeling individual and relative accuracy of screening tools in geriatric oncology, Ann. Oncol, vol.28, pp.1152-1157, 2017. ,
Relevance of a systematic geriatric screening and assessment in older patients with cancer: Results of a prospective multicentric study, Ann. Oncol, vol.24, pp.1306-1312, 2013. ,
Adherence to geriatric assessment-based recommendations in older patients with cancer: A multicenter prospective cohort study in Belgium, Ann. Oncol, vol.29, 1987. ,
Geriatric assessment with management in cancer care: Current evidence and potential mechanisms for future research, J. Geriatr. Oncol, vol.7, pp.242-248, 2016. ,
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology Summary, J. Oncol. Pract, vol.14, pp.442-446, 2018. ,
, , vol.104, pp.816-819, 2017.
Treatment of inoperable elderly Head and Neck cancer patients, Curr. Opin. Oncol, 2019. ,
The ELAN-ONCOVAL (ELderly heAd and Neck cancer-Oncology eValuation) study: Evaluation of the feasibility of a suited geriatric assessment for use by oncologists to classify patients as fit or unfit, Proceedings of the ESMO 2017 Congress, pp.8-12, 2017. ,
Predicting early death in older adults with cancer, Eur. J. Cancer, vol.100, pp.65-74, 2018. ,
Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients, Cancers, vol.10, 2018. ,
Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma, Cancers, vol.9, p.326, 2018. ,
Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): Protocol of a prospective multicentre cohort study in France, BMJ Open, vol.7, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01744875
Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How? Cancers, vol.10, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01834086
The "one airway, one disease" concept in light of Th2 inflammation, Eur. Respir. J, vol.52, 2018. ,
Effect of mutant variants of the KRAS gene on PD-L1 expression and on the immune microenvironment and association with clinical outcome in lung adenocarcinoma patients, Lung Cancer, vol.121, pp.70-75, 2018. ,
Detection of PD-L1 in circulating tumor cells and white blood cells from patients with advanced non-small-cell lung cancer, Ann. Oncol, vol.29, pp.193-199, 2018. ,
A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM), Am. J. Respir. Crit. Care Med, vol.196, pp.1535-1543, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01963139
CDC20B is required for deuterosome-mediated centriole production in multiciliated cells, Nat. Commun, vol.9, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02064869
Lung Cancer Screening, Towards a Multidimensional Approach: Why and How? Cancers, vol.11, 2019. ,
The Desire to Better Understand Older Adults with Solid Tumors to Improve Management: Assessment and Guided Interventions-The French PACA EST Cohort Experience, Cancers, vol.11, 0192. ,
Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): Health-related quality-of-life results from a randomised, vol.18, pp.1104-1115, 2017. ,
Vouret-Craviari, V. MiR-223-3p inhibits angiogenesis and promotes resistance to cetuximab in head and neck squamous cell carcinoma, Oncotarget, vol.8, pp.57174-57186, 2017. ,
Fueling the sustainability of Next Generation Biobanks by training. A New Master "Biobanks and Complex Data Management" at the Nice Côte d'Azur University, Proceedings of the Global Biobank Week, pp.13-15, 2017. ,
Lung cancer, elderly and immune checkpoint inhibitors, J. Thorac. Dis, vol.10, pp.1474-1481, 2018. ,
Immune checkpoint inhibitors and elderly people: A review, Eur. J. Cancer, vol.82, pp.155-166, 2017. ,
Aging, immune senescence, and immunotherapy: A comprehensive review, Semin. Oncol, vol.45, pp.187-200, 2018. ,
The development of immunotherapy in older adults: New treatments, new toxicities?, J. Geriatr. Oncol, vol.7, pp.325-333, 2016. ,
Immunotherapy in Older Adults With Advanced Cancers: Implications for Clinical Decision-Making and Future Research, Am. Soc. Clin. Oncol. Educ. Book, pp.400-414, 2018. ,
Are aging biomarkers clinically relevant in oncogeriatrics?, Crit. Rev. Oncol. Hematol, vol.85, pp.257-265, 2013. ,
Immunosenescence and immunecheckpoint inhibitors in non-small cell lung cancer patients: Does age really matter? Cancer Treat, vol.60, pp.60-68, 2017. ,